Deutsches Krebsforschungszentrum (German Cancer Research Center, Heidelberg, Germany)
Jörg Hoheisel heads the Division of Functional Genome Analysis at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. Simultaneously, he is chairman of the DKFZ Scientific Council and member of the institute’s Board of Trustees.
His research objectives are the assessment and description of the realisation of cellular function from genetic information. There is a current focus on the analysis of protein variations and interactions by means of affinity proteomics. Another line of work is Synthetic Biology for the in vitro production of functional biomolecules and the establishment of artificial molecular systems. Earlier achievements were his involvement in sequencing the yeast genome as a coordinator and early developments in the area of microarray technology. Jörg also co-founded four companies.
Prior to joining DKFZ, Jörg worked for 5 years at the Imperial Cancer Research Fund in London, UK, the initial 2 years funded by an EMBO fellowship. His scientific emphasis then was genome mapping as a preparation for subsequent sequencing. Previously, he had studied molecular biology at the University of Constance, Germany. He finished his PhD with distinction (summa cum laude) on the subjects of topologically induced DNA-structures and the functioning of DNA-binding enzymes.